Zuno Medical

Coming – January 13

Fixing the #1 Constraint To Surgical Throughput

Date and Time

January 13

–

12:00 PM ET / 9:00 AM PT

Details will be provided upon RSVP approval

About this Event

The Zuno Smart Container is a breakthrough technology addressing one of healthcare’s most costly and overlooked bottlenecks: surgical sterilization.

Today, sterilization capacity is the #1 constraint to growing surgical revenue across hospitals and ambulatory surgery centers. A single contaminated instrument set can delay or cancel surgery, costing facilities thousands of dollars per hour while negatively impacting patient care.

The Zuno Smart Container is an FDA De Novo–cleared, vacuum-sealed smart sterilization container that reduces total instrument processing time by over 75%, eliminates sterile barrier failures, and enables faster OR turnover.

Zuno has four live deployments, all of which are paying full list price. The surgery centers that have adopted Smart Containers have increased weekly case volume by up to 75% without adding staff, space, or capital equipment.

Join our webinar with Zuno Medical CEO, Allan McNichol, to learn how the company delivers clear clinical ROI, strong patent protection, and a recurring subscription model in a large, innovation-starved market.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.